NEXGEL, Inc. (NASDAQ: NXGL) Stock Competitors & Peer Comparison
See NXGL's competitors and their performance on the NASDAQ and across the wider stock market.
Peer Comparison Table: Medical - Instruments & Supplies Industry
Detailed financial metrics including price, market cap, P/E ratio, and more for NXGL and its NASDAQ peers.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| NXGL | $4.11 | +3.83% | 90.2K | -6.08 | -$0.70 | N/A |
| ISRG | $446.79 | -1.07% | 157.5B | 46.35 | $9.62 | N/A |
| BDXA | $59.24 | -2.24% | 55.9B | 45.70 | $1.30 | +2.03% |
| BDX | $193.92 | -1.26% | 53.1B | 15.00 | $13.00 | +2.03% |
| RMD | $251.03 | -0.86% | 35.3B | 23.28 | $10.77 | +0.98% |
| MDLN | $32.53 | -3.46% | 28.4B | 23.73 | $1.36 | N/A |
| WST | $401.04 | +1.60% | 28B | 46.85 | $8.50 | +0.22% |
| HOLX | $76.01 | +0.00% | 17B | 31.54 | $2.41 | N/A |
| SOLV | $82.06 | -4.37% | 14.1B | 11.69 | $7.10 | N/A |
| BDXB | $48.16 | +1.39% | 13.7B | 7.60 | $6.33 | +2.03% |
Stock Comparison
Intuitive Surgical, Inc. (NASDAQ: ISRG)
NXGL vs ISRG Comparison October 2026
NEXGEL, Inc. (NASDAQ: NXGL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGL stands at 90.2K. In comparison, ISRG has a market cap of 157.5B. Regarding current trading prices, NXGL is priced at $4.11 on the NASDAQ, while ISRG trades at $446.79.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGL currently has a P/E ratio of -6.08, whereas ISRG's P/E ratio is 46.35. In terms of profitability, NXGL's ROE is -1.33%, compared to ISRG's ROE of +0.17%. Regarding short-term risk, NXGL is more volatile compared to ISRG. This indicates higher risk in terms of short-term price fluctuations for NXGL.Check ISRG's competition here
Becton, Dickinson and Company (NYSE: BDXA)
NXGL vs BDXA Comparison October 2026
NEXGEL, Inc. (NASDAQ: NXGL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGL stands at 90.2K. In comparison, BDXA has a market cap of 55.9B. Regarding current trading prices, NXGL is priced at $4.11 on the NASDAQ, while BDXA trades at $59.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGL currently has a P/E ratio of -6.08, whereas BDXA's P/E ratio is 45.70. In terms of profitability, NXGL's ROE is -1.33%, compared to BDXA's ROE of +0.04%. Regarding short-term risk, NXGL is more volatile compared to BDXA. This indicates higher risk in terms of short-term price fluctuations for NXGL.Check BDXA's competition here
Becton, Dickinson and Company (NYSE: BDX)
NXGL vs BDX Comparison October 2026
NEXGEL, Inc. (NASDAQ: NXGL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGL stands at 90.2K. In comparison, BDX has a market cap of 53.1B. Regarding current trading prices, NXGL is priced at $4.11 on the NASDAQ, while BDX trades at $193.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGL currently has a P/E ratio of -6.08, whereas BDX's P/E ratio is 15.00. In terms of profitability, NXGL's ROE is -1.33%, compared to BDX's ROE of +0.04%. Regarding short-term risk, NXGL is more volatile compared to BDX. This indicates higher risk in terms of short-term price fluctuations for NXGL.Check BDX's competition here
ResMed Inc. (NYSE: RMD)
NXGL vs RMD Comparison October 2026
NEXGEL, Inc. (NASDAQ: NXGL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGL stands at 90.2K. In comparison, RMD has a market cap of 35.3B. Regarding current trading prices, NXGL is priced at $4.11 on the NASDAQ, while RMD trades at $251.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGL currently has a P/E ratio of -6.08, whereas RMD's P/E ratio is 23.28. In terms of profitability, NXGL's ROE is -1.33%, compared to RMD's ROE of +0.24%. Regarding short-term risk, NXGL is more volatile compared to RMD. This indicates higher risk in terms of short-term price fluctuations for NXGL.Check RMD's competition here
Medline Inc. (NASDAQ: MDLN)
NXGL vs MDLN Comparison October 2026
NEXGEL, Inc. (NASDAQ: NXGL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGL stands at 90.2K. In comparison, MDLN has a market cap of 28.4B. Regarding current trading prices, NXGL is priced at $4.11 on the NASDAQ, while MDLN trades at $32.53.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGL currently has a P/E ratio of -6.08, whereas MDLN's P/E ratio is 23.73. In terms of profitability, NXGL's ROE is -1.33%, compared to MDLN's ROE of +0.05%. Regarding short-term risk, NXGL is more volatile compared to MDLN. This indicates higher risk in terms of short-term price fluctuations for NXGL.Check MDLN's competition here
West Pharmaceutical Services, Inc. (NYSE: WST)
NXGL vs WST Comparison October 2026
NEXGEL, Inc. (NASDAQ: NXGL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGL stands at 90.2K. In comparison, WST has a market cap of 28B. Regarding current trading prices, NXGL is priced at $4.11 on the NASDAQ, while WST trades at $401.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGL currently has a P/E ratio of -6.08, whereas WST's P/E ratio is 46.85. In terms of profitability, NXGL's ROE is -1.33%, compared to WST's ROE of +0.19%. Regarding short-term risk, NXGL is more volatile compared to WST. This indicates higher risk in terms of short-term price fluctuations for NXGL.Check WST's competition here
Hologic, Inc. (NASDAQ: HOLX)
NXGL vs HOLX Comparison October 2026
NEXGEL, Inc. (NASDAQ: NXGL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGL stands at 90.2K. In comparison, HOLX has a market cap of 17B. Regarding current trading prices, NXGL is priced at $4.11 on the NASDAQ, while HOLX trades at $76.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGL currently has a P/E ratio of -6.08, whereas HOLX's P/E ratio is 31.54. In terms of profitability, NXGL's ROE is -1.33%, compared to HOLX's ROE of +0.11%. Regarding short-term risk, NXGL is more volatile compared to HOLX. This indicates higher risk in terms of short-term price fluctuations for NXGL.Check HOLX's competition here
Solventum Corporation (NYSE: SOLV)
NXGL vs SOLV Comparison October 2026
NEXGEL, Inc. (NASDAQ: NXGL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGL stands at 90.2K. In comparison, SOLV has a market cap of 14.1B. Regarding current trading prices, NXGL is priced at $4.11 on the NASDAQ, while SOLV trades at $82.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGL currently has a P/E ratio of -6.08, whereas SOLV's P/E ratio is 11.69. In terms of profitability, NXGL's ROE is -1.33%, compared to SOLV's ROE of +0.29%. Regarding short-term risk, NXGL is more volatile compared to SOLV. This indicates higher risk in terms of short-term price fluctuations for NXGL.Check SOLV's competition here
Becton, Dickinson and Company (NYSE: BDXB)
NXGL vs BDXB Comparison October 2026
NEXGEL, Inc. (NASDAQ: NXGL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGL stands at 90.2K. In comparison, BDXB has a market cap of 13.7B. Regarding current trading prices, NXGL is priced at $4.11 on the NASDAQ, while BDXB trades at $48.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGL currently has a P/E ratio of -6.08, whereas BDXB's P/E ratio is 7.60. In terms of profitability, NXGL's ROE is -1.33%, compared to BDXB's ROE of +0.04%. Regarding short-term risk, NXGL is more volatile compared to BDXB. This indicates higher risk in terms of short-term price fluctuations for NXGL.Check BDXB's competition here
Baxter International Inc. (NYSE: BAX)
NXGL vs BAX Comparison October 2026
NEXGEL, Inc. (NASDAQ: NXGL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGL stands at 90.2K. In comparison, BAX has a market cap of 12.9B. Regarding current trading prices, NXGL is priced at $4.11 on the NASDAQ, while BAX trades at $25.62.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGL currently has a P/E ratio of -6.08, whereas BAX's P/E ratio is 11.98. In terms of profitability, NXGL's ROE is -1.33%, compared to BAX's ROE of -0.17%. Regarding short-term risk, NXGL is more volatile compared to BAX. This indicates higher risk in terms of short-term price fluctuations for NXGL.Check BAX's competition here
Avantor, Inc. (NYSE: AVTR)
NXGL vs AVTR Comparison October 2026
NEXGEL, Inc. (NASDAQ: NXGL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGL stands at 90.2K. In comparison, AVTR has a market cap of 11.6B. Regarding current trading prices, NXGL is priced at $4.11 on the NASDAQ, while AVTR trades at $16.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGL currently has a P/E ratio of -6.08, whereas AVTR's P/E ratio is 20.14. In terms of profitability, NXGL's ROE is -1.33%, compared to AVTR's ROE of -0.10%. Regarding short-term risk, NXGL is more volatile compared to AVTR. This indicates higher risk in terms of short-term price fluctuations for NXGL.Check AVTR's competition here
The Cooper Companies, Inc. (NASDAQ: COO)
NXGL vs COO Comparison October 2026
NEXGEL, Inc. (NASDAQ: NXGL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGL stands at 90.2K. In comparison, COO has a market cap of 11.4B. Regarding current trading prices, NXGL is priced at $4.11 on the NASDAQ, while COO trades at $59.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGL currently has a P/E ratio of -6.08, whereas COO's P/E ratio is 13.13. In terms of profitability, NXGL's ROE is -1.33%, compared to COO's ROE of +0.07%. Regarding short-term risk, NXGL is more volatile compared to COO. This indicates higher risk in terms of short-term price fluctuations for NXGL.Check COO's competition here
Repligen Corporation (NASDAQ: RGEN)
NXGL vs RGEN Comparison October 2026
NEXGEL, Inc. (NASDAQ: NXGL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGL stands at 90.2K. In comparison, RGEN has a market cap of 11.2B. Regarding current trading prices, NXGL is priced at $4.11 on the NASDAQ, while RGEN trades at $184.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGL currently has a P/E ratio of -6.08, whereas RGEN's P/E ratio is 97.67. In terms of profitability, NXGL's ROE is -1.33%, compared to RGEN's ROE of -0.01%. Regarding short-term risk, NXGL is more volatile compared to RGEN. This indicates higher risk in terms of short-term price fluctuations for NXGL.Check RGEN's competition here
AptarGroup, Inc. (NYSE: ATR)
NXGL vs ATR Comparison October 2026
NEXGEL, Inc. (NASDAQ: NXGL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGL stands at 90.2K. In comparison, ATR has a market cap of 8B. Regarding current trading prices, NXGL is priced at $4.11 on the NASDAQ, while ATR trades at $126.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGL currently has a P/E ratio of -6.08, whereas ATR's P/E ratio is 22.12. In terms of profitability, NXGL's ROE is -1.33%, compared to ATR's ROE of +0.14%. Regarding short-term risk, NXGL is more volatile compared to ATR. This indicates higher risk in terms of short-term price fluctuations for NXGL.Check ATR's competition here
Bausch + Lomb Corporation (NYSE: BLCO)
NXGL vs BLCO Comparison October 2026
NEXGEL, Inc. (NASDAQ: NXGL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGL stands at 90.2K. In comparison, BLCO has a market cap of 6.3B. Regarding current trading prices, NXGL is priced at $4.11 on the NASDAQ, while BLCO trades at $19.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGL currently has a P/E ratio of -6.08, whereas BLCO's P/E ratio is 27.11. In terms of profitability, NXGL's ROE is -1.33%, compared to BLCO's ROE of -0.03%. Regarding short-term risk, NXGL is more volatile compared to BLCO. This indicates higher risk in terms of short-term price fluctuations for NXGL.Check BLCO's competition here
Teleflex Incorporated (NYSE: TFX)
NXGL vs TFX Comparison October 2026
NEXGEL, Inc. (NASDAQ: NXGL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGL stands at 90.2K. In comparison, TFX has a market cap of 5.9B. Regarding current trading prices, NXGL is priced at $4.11 on the NASDAQ, while TFX trades at $137.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGL currently has a P/E ratio of -6.08, whereas TFX's P/E ratio is 15.90. In terms of profitability, NXGL's ROE is -1.33%, compared to TFX's ROE of -0.32%. Regarding short-term risk, NXGL is more volatile compared to TFX. This indicates higher risk in terms of short-term price fluctuations for NXGL.Check TFX's competition here
Merit Medical Systems, Inc. (NASDAQ: MMSI)
NXGL vs MMSI Comparison October 2026
NEXGEL, Inc. (NASDAQ: NXGL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGL stands at 90.2K. In comparison, MMSI has a market cap of 5.6B. Regarding current trading prices, NXGL is priced at $4.11 on the NASDAQ, while MMSI trades at $92.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGL currently has a P/E ratio of -6.08, whereas MMSI's P/E ratio is 23.92. In terms of profitability, NXGL's ROE is -1.33%, compared to MMSI's ROE of +0.09%. Regarding short-term risk, NXGL is more volatile compared to MMSI. This indicates higher risk in terms of short-term price fluctuations for NXGL.Check MMSI's competition here
Stevanato Group S.p.A. (NYSE: STVN)
NXGL vs STVN Comparison October 2026
NEXGEL, Inc. (NASDAQ: NXGL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGL stands at 90.2K. In comparison, STVN has a market cap of 5.4B. Regarding current trading prices, NXGL is priced at $4.11 on the NASDAQ, while STVN trades at $19.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGL currently has a P/E ratio of -6.08, whereas STVN's P/E ratio is 29.76. In terms of profitability, NXGL's ROE is -1.33%, compared to STVN's ROE of +0.09%. Regarding short-term risk, NXGL is more volatile compared to STVN. This indicates higher risk in terms of short-term price fluctuations for NXGL.Check STVN's competition here
ICU Medical, Inc. (NASDAQ: ICUI)
NXGL vs ICUI Comparison October 2026
NEXGEL, Inc. (NASDAQ: NXGL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGL stands at 90.2K. In comparison, ICUI has a market cap of 4.1B. Regarding current trading prices, NXGL is priced at $4.11 on the NASDAQ, while ICUI trades at $165.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGL currently has a P/E ratio of -6.08, whereas ICUI's P/E ratio is 20.37. In terms of profitability, NXGL's ROE is -1.33%, compared to ICUI's ROE of +0.01%. Regarding short-term risk, NXGL is more volatile compared to ICUI. This indicates higher risk in terms of short-term price fluctuations for NXGL.Check ICUI's competition here
Pulse Biosciences, Inc. (NASDAQ: PLSE)
NXGL vs PLSE Comparison October 2026
NEXGEL, Inc. (NASDAQ: NXGL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGL stands at 90.2K. In comparison, PLSE has a market cap of 3.8B. Regarding current trading prices, NXGL is priced at $4.11 on the NASDAQ, while PLSE trades at $53.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGL currently has a P/E ratio of -6.08, whereas PLSE's P/E ratio is -45.08. In terms of profitability, NXGL's ROE is -1.33%, compared to PLSE's ROE of -0.94%. Regarding short-term risk, NXGL is more volatile compared to PLSE. This indicates higher risk in terms of short-term price fluctuations for NXGL.Check PLSE's competition here
Envista Holdings Corp (NYSE: NVST)
NXGL vs NVST Comparison October 2026
NEXGEL, Inc. (NASDAQ: NXGL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGL stands at 90.2K. In comparison, NVST has a market cap of 3.8B. Regarding current trading prices, NXGL is priced at $4.11 on the NASDAQ, while NVST trades at $23.67.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGL currently has a P/E ratio of -6.08, whereas NVST's P/E ratio is 16.04. In terms of profitability, NXGL's ROE is -1.33%, compared to NVST's ROE of +0.03%. Regarding short-term risk, NXGL is more volatile compared to NVST. This indicates higher risk in terms of short-term price fluctuations for NXGL.Check NVST's competition here
AtriCure, Inc. (NASDAQ: ATRC)
NXGL vs ATRC Comparison October 2026
NEXGEL, Inc. (NASDAQ: NXGL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGL stands at 90.2K. In comparison, ATRC has a market cap of 3.1B. Regarding current trading prices, NXGL is priced at $4.11 on the NASDAQ, while ATRC trades at $61.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGL currently has a P/E ratio of -6.08, whereas ATRC's P/E ratio is 1910.25. In terms of profitability, NXGL's ROE is -1.33%, compared to ATRC's ROE of +0.02%. Regarding short-term risk, NXGL is more volatile compared to ATRC. This indicates higher risk in terms of short-term price fluctuations for NXGL.Check ATRC's competition here
LeMaitre Vascular, Inc. (NASDAQ: LMAT)
NXGL vs LMAT Comparison October 2026
NEXGEL, Inc. (NASDAQ: NXGL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGL stands at 90.2K. In comparison, LMAT has a market cap of 1.9B. Regarding current trading prices, NXGL is priced at $4.11 on the NASDAQ, while LMAT trades at $83.67.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGL currently has a P/E ratio of -6.08, whereas LMAT's P/E ratio is 30.81. In terms of profitability, NXGL's ROE is -1.33%, compared to LMAT's ROE of +0.16%. Regarding short-term risk, NXGL is more volatile compared to LMAT. This indicates higher risk in terms of short-term price fluctuations for NXGL.Check LMAT's competition here
BioLife Solutions, Inc. (NASDAQ: BLFS)
NXGL vs BLFS Comparison October 2026
NEXGEL, Inc. (NASDAQ: NXGL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGL stands at 90.2K. In comparison, BLFS has a market cap of 1.9B. Regarding current trading prices, NXGL is priced at $4.11 on the NASDAQ, while BLFS trades at $38.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGL currently has a P/E ratio of -6.08, whereas BLFS's P/E ratio is 37.49. In terms of profitability, NXGL's ROE is -1.33%, compared to BLFS's ROE of +0.13%. Regarding short-term risk, NXGL is more volatile compared to BLFS. This indicates higher risk in terms of short-term price fluctuations for NXGL.Check BLFS's competition here
DENTSPLY SIRONA Inc. (NASDAQ: XRAY)
NXGL vs XRAY Comparison October 2026
NEXGEL, Inc. (NASDAQ: NXGL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGL stands at 90.2K. In comparison, XRAY has a market cap of 1.9B. Regarding current trading prices, NXGL is priced at $4.11 on the NASDAQ, while XRAY trades at $9.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGL currently has a P/E ratio of -6.08, whereas XRAY's P/E ratio is 6.54. In terms of profitability, NXGL's ROE is -1.33%, compared to XRAY's ROE of -0.40%. Regarding short-term risk, NXGL is more volatile compared to XRAY. This indicates higher risk in terms of short-term price fluctuations for NXGL.Check XRAY's competition here
Kestra Medical Technologies, Ltd. (NASDAQ: KMTS)
NXGL vs KMTS Comparison October 2026
NEXGEL, Inc. (NASDAQ: NXGL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGL stands at 90.2K. In comparison, KMTS has a market cap of 1.8B. Regarding current trading prices, NXGL is priced at $4.11 on the NASDAQ, while KMTS trades at $30.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGL currently has a P/E ratio of -6.08, whereas KMTS's P/E ratio is -11.32. In terms of profitability, NXGL's ROE is -1.33%, compared to KMTS's ROE of -0.64%. Regarding short-term risk, NXGL is more volatile compared to KMTS. This indicates higher risk in terms of short-term price fluctuations for NXGL.Check KMTS's competition here
Azenta, Inc. (NASDAQ: AZTA)
NXGL vs AZTA Comparison October 2026
NEXGEL, Inc. (NASDAQ: NXGL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGL stands at 90.2K. In comparison, AZTA has a market cap of 1.7B. Regarding current trading prices, NXGL is priced at $4.11 on the NASDAQ, while AZTA trades at $40.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGL currently has a P/E ratio of -6.08, whereas AZTA's P/E ratio is 93.05. In terms of profitability, NXGL's ROE is -1.33%, compared to AZTA's ROE of -0.08%. Regarding short-term risk, NXGL is more volatile compared to AZTA. This indicates higher risk in terms of short-term price fluctuations for NXGL.Check AZTA's competition here
STAAR Surgical Company (NASDAQ: STAA)
NXGL vs STAA Comparison October 2026
NEXGEL, Inc. (NASDAQ: NXGL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGL stands at 90.2K. In comparison, STAA has a market cap of 1.2B. Regarding current trading prices, NXGL is priced at $4.11 on the NASDAQ, while STAA trades at $24.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGL currently has a P/E ratio of -6.08, whereas STAA's P/E ratio is 42.39. In terms of profitability, NXGL's ROE is -1.33%, compared to STAA's ROE of +0.01%. Regarding short-term risk, NXGL is more volatile compared to STAA. This indicates higher risk in terms of short-term price fluctuations for NXGL.Check STAA's competition here
Atrion Corporation (NASDAQ: ATRI)
NXGL vs ATRI Comparison October 2026
NEXGEL, Inc. (NASDAQ: NXGL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGL stands at 90.2K. In comparison, ATRI has a market cap of 809.4M. Regarding current trading prices, NXGL is priced at $4.11 on the NASDAQ, while ATRI trades at $459.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGL currently has a P/E ratio of -6.08, whereas ATRI's P/E ratio is 64.50. In terms of profitability, NXGL's ROE is -1.33%, compared to ATRI's ROE of +0.08%. Regarding short-term risk, NXGL is more volatile compared to ATRI. This indicates higher risk in terms of short-term price fluctuations for NXGL.Check ATRI's competition here
AngioDynamics, Inc. (NASDAQ: ANGO)
NXGL vs ANGO Comparison October 2026
NEXGEL, Inc. (NASDAQ: NXGL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGL stands at 90.2K. In comparison, ANGO has a market cap of 515.6M. Regarding current trading prices, NXGL is priced at $4.11 on the NASDAQ, while ANGO trades at $12.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGL currently has a P/E ratio of -6.08, whereas ANGO's P/E ratio is -31.44. In terms of profitability, NXGL's ROE is -1.33%, compared to ANGO's ROE of -0.19%. Regarding short-term risk, NXGL is more volatile compared to ANGO. This indicates higher risk in terms of short-term price fluctuations for NXGL.Check ANGO's competition here
MiniMed Group, Inc. (NASDAQ: MMEDV)
NXGL vs MMEDV Comparison October 2026
NEXGEL, Inc. (NASDAQ: NXGL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGL stands at 90.2K. In comparison, MMEDV has a market cap of 495.6M. Regarding current trading prices, NXGL is priced at $4.11 on the NASDAQ, while MMEDV trades at $17.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGL currently has a P/E ratio of -6.08, whereas MMEDV's P/E ratio is N/A. In terms of profitability, NXGL's ROE is -1.33%, compared to MMEDV's ROE of N/A. Regarding short-term risk, NXGL is more volatile compared to MMEDV. This indicates higher risk in terms of short-term price fluctuations for NXGL.Check MMEDV's competition here
Embecta Corp. (NASDAQ: EMBC)
NXGL vs EMBC Comparison October 2026
NEXGEL, Inc. (NASDAQ: NXGL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGL stands at 90.2K. In comparison, EMBC has a market cap of 371.1M. Regarding current trading prices, NXGL is priced at $4.11 on the NASDAQ, while EMBC trades at $6.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGL currently has a P/E ratio of -6.08, whereas EMBC's P/E ratio is 2.52. In terms of profitability, NXGL's ROE is -1.33%, compared to EMBC's ROE of -0.14%. Regarding short-term risk, NXGL is more volatile compared to EMBC. This indicates higher risk in terms of short-term price fluctuations for NXGL.Check EMBC's competition here
Sanara MedTech Inc. (NASDAQ: SMTI)
NXGL vs SMTI Comparison October 2026
NEXGEL, Inc. (NASDAQ: NXGL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGL stands at 90.2K. In comparison, SMTI has a market cap of 301.7M. Regarding current trading prices, NXGL is priced at $4.11 on the NASDAQ, while SMTI trades at $32.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGL currently has a P/E ratio of -6.08, whereas SMTI's P/E ratio is -547.33. In terms of profitability, NXGL's ROE is -1.33%, compared to SMTI's ROE of -4.74%. Regarding short-term risk, NXGL is more volatile compared to SMTI. This indicates higher risk in terms of short-term price fluctuations for NXGL.Check SMTI's competition here
OraSure Technologies, Inc. (NASDAQ: OSUR)
NXGL vs OSUR Comparison October 2026
NEXGEL, Inc. (NASDAQ: NXGL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGL stands at 90.2K. In comparison, OSUR has a market cap of 286.9M. Regarding current trading prices, NXGL is priced at $4.11 on the NASDAQ, while OSUR trades at $4.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGL currently has a P/E ratio of -6.08, whereas OSUR's P/E ratio is -6.03. In terms of profitability, NXGL's ROE is -1.33%, compared to OSUR's ROE of -0.15%. Regarding short-term risk, NXGL is more volatile compared to OSUR. This indicates higher risk in terms of short-term price fluctuations for NXGL.Check OSUR's competition here
Utah Medical Products, Inc. (NASDAQ: UTMD)
NXGL vs UTMD Comparison October 2026
NEXGEL, Inc. (NASDAQ: NXGL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGL stands at 90.2K. In comparison, UTMD has a market cap of 231.9M. Regarding current trading prices, NXGL is priced at $4.11 on the NASDAQ, while UTMD trades at $70.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGL currently has a P/E ratio of -6.08, whereas UTMD's P/E ratio is 21.62. In terms of profitability, NXGL's ROE is -1.33%, compared to UTMD's ROE of +0.09%. Regarding short-term risk, NXGL is more volatile compared to UTMD. This indicates higher risk in terms of short-term price fluctuations for NXGL.Check UTMD's competition here
Pro-Dex, Inc. (NASDAQ: PDEX)
NXGL vs PDEX Comparison October 2026
NEXGEL, Inc. (NASDAQ: NXGL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGL stands at 90.2K. In comparison, PDEX has a market cap of 201.3M. Regarding current trading prices, NXGL is priced at $4.11 on the NASDAQ, while PDEX trades at $62.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGL currently has a P/E ratio of -6.08, whereas PDEX's P/E ratio is 15.08. In terms of profitability, NXGL's ROE is -1.33%, compared to PDEX's ROE of +0.31%. Regarding short-term risk, NXGL is more volatile compared to PDEX. This indicates higher risk in terms of short-term price fluctuations for NXGL.Check PDEX's competition here
Anbio Biotechnology Class A Ordinary Shares (NASDAQ: NNNN)
NXGL vs NNNN Comparison October 2026
NEXGEL, Inc. (NASDAQ: NXGL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGL stands at 90.2K. In comparison, NNNN has a market cap of 169.4M. Regarding current trading prices, NXGL is priced at $4.11 on the NASDAQ, while NNNN trades at $3.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGL currently has a P/E ratio of -6.08, whereas NNNN's P/E ratio is 25.73. In terms of profitability, NXGL's ROE is -1.33%, compared to NNNN's ROE of +0.27%. Regarding short-term risk, NXGL is more volatile compared to NNNN. This indicates higher risk in terms of short-term price fluctuations for NXGL.Check NNNN's competition here
KORU Medical Systems, Inc. (NASDAQ: KRMD)
NXGL vs KRMD Comparison October 2026
NEXGEL, Inc. (NASDAQ: NXGL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGL stands at 90.2K. In comparison, KRMD has a market cap of 145.6M. Regarding current trading prices, NXGL is priced at $4.11 on the NASDAQ, while KRMD trades at $3.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGL currently has a P/E ratio of -6.08, whereas KRMD's P/E ratio is -79.25. In terms of profitability, NXGL's ROE is -1.33%, compared to KRMD's ROE of -0.11%. Regarding short-term risk, NXGL is more volatile compared to KRMD. This indicates higher risk in terms of short-term price fluctuations for NXGL.Check KRMD's competition here
Stereotaxis, Inc. (AMEX: STXS)
NXGL vs STXS Comparison October 2026
NEXGEL, Inc. (NASDAQ: NXGL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGL stands at 90.2K. In comparison, STXS has a market cap of 104.2M. Regarding current trading prices, NXGL is priced at $4.11 on the NASDAQ, while STXS trades at $1.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGL currently has a P/E ratio of -6.08, whereas STXS's P/E ratio is -6.12. In terms of profitability, NXGL's ROE is -1.33%, compared to STXS's ROE of -1.33%. Regarding short-term risk, NXGL is more volatile compared to STXS. This indicates higher risk in terms of short-term price fluctuations for NXGL.Check STXS's competition here
Akoya Biosciences, Inc. (NASDAQ: AKYA)
NXGL vs AKYA Comparison October 2026
NEXGEL, Inc. (NASDAQ: NXGL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGL stands at 90.2K. In comparison, AKYA has a market cap of 64.4M. Regarding current trading prices, NXGL is priced at $4.11 on the NASDAQ, while AKYA trades at $1.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGL currently has a P/E ratio of -6.08, whereas AKYA's P/E ratio is -1.34. In terms of profitability, NXGL's ROE is -1.33%, compared to AKYA's ROE of -1.80%. Regarding short-term risk, NXGL is more volatile compared to AKYA. This indicates higher risk in terms of short-term price fluctuations for NXGL.Check AKYA's competition here
Daxor Corporation (NASDAQ: DXR)
NXGL vs DXR Comparison October 2026
NEXGEL, Inc. (NASDAQ: NXGL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGL stands at 90.2K. In comparison, DXR has a market cap of 54.1M. Regarding current trading prices, NXGL is priced at $4.11 on the NASDAQ, while DXR trades at $9.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGL currently has a P/E ratio of -6.08, whereas DXR's P/E ratio is 7.54. In terms of profitability, NXGL's ROE is -1.33%, compared to DXR's ROE of +0.13%. Regarding short-term risk, NXGL is more volatile compared to DXR. This indicates higher risk in terms of short-term price fluctuations for NXGL.Check DXR's competition here
SkyAI, Inc. (NASDAQ: STSS)
NXGL vs STSS Comparison October 2026
NEXGEL, Inc. (NASDAQ: NXGL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGL stands at 90.2K. In comparison, STSS has a market cap of 53.7M. Regarding current trading prices, NXGL is priced at $4.11 on the NASDAQ, while STSS trades at $1.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGL currently has a P/E ratio of -6.08, whereas STSS's P/E ratio is -0.02. In terms of profitability, NXGL's ROE is -1.33%, compared to STSS's ROE of -1.54%. Regarding short-term risk, NXGL is more volatile compared to STSS. This indicates higher risk in terms of short-term price fluctuations for NXGL.Check STSS's competition here
Singular Genomics Systems, Inc. (NASDAQ: OMIC)
NXGL vs OMIC Comparison October 2026
NEXGEL, Inc. (NASDAQ: NXGL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGL stands at 90.2K. In comparison, OMIC has a market cap of 50.8M. Regarding current trading prices, NXGL is priced at $4.11 on the NASDAQ, while OMIC trades at $20.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGL currently has a P/E ratio of -6.08, whereas OMIC's P/E ratio is -0.58. In terms of profitability, NXGL's ROE is -1.33%, compared to OMIC's ROE of -0.43%. Regarding short-term risk, NXGL is more volatile compared to OMIC. This indicates higher risk in terms of short-term price fluctuations for NXGL.Check OMIC's competition here
GlucoTrack, Inc. (NASDAQ: IGAP)
NXGL vs IGAP Comparison October 2026
NEXGEL, Inc. (NASDAQ: NXGL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGL stands at 90.2K. In comparison, IGAP has a market cap of 50.2M. Regarding current trading prices, NXGL is priced at $4.11 on the NASDAQ, while IGAP trades at $3.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGL currently has a P/E ratio of -6.08, whereas IGAP's P/E ratio is -10.52. In terms of profitability, NXGL's ROE is -1.33%, compared to IGAP's ROE of +1.80%. Regarding short-term risk, NXGL is more volatile compared to IGAP. This indicates higher risk in terms of short-term price fluctuations for NXGL.Check IGAP's competition here
Precision Optics Corporation, Inc. (NASDAQ: POCI)
NXGL vs POCI Comparison October 2026
NEXGEL, Inc. (NASDAQ: NXGL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGL stands at 90.2K. In comparison, POCI has a market cap of 48.4M. Regarding current trading prices, NXGL is priced at $4.11 on the NASDAQ, while POCI trades at $4.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGL currently has a P/E ratio of -6.08, whereas POCI's P/E ratio is -9.59. In terms of profitability, NXGL's ROE is -1.33%, compared to POCI's ROE of -0.24%. Regarding short-term risk, NXGL is more volatile compared to POCI. This indicates higher risk in terms of short-term price fluctuations for NXGL.Check POCI's competition here
Harvard Bioscience, Inc. (NASDAQ: HBIO)
NXGL vs HBIO Comparison October 2026
NEXGEL, Inc. (NASDAQ: NXGL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGL stands at 90.2K. In comparison, HBIO has a market cap of 38M. Regarding current trading prices, NXGL is priced at $4.11 on the NASDAQ, while HBIO trades at $8.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGL currently has a P/E ratio of -6.08, whereas HBIO's P/E ratio is -23.19. In terms of profitability, NXGL's ROE is -1.33%, compared to HBIO's ROE of -0.92%. Regarding short-term risk, NXGL is more volatile compared to HBIO. This indicates higher risk in terms of short-term price fluctuations for NXGL.Check HBIO's competition here
Nephros, Inc. (NASDAQ: NEPH)
NXGL vs NEPH Comparison October 2026
NEXGEL, Inc. (NASDAQ: NXGL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGL stands at 90.2K. In comparison, NEPH has a market cap of 36.6M. Regarding current trading prices, NXGL is priced at $4.11 on the NASDAQ, while NEPH trades at $3.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGL currently has a P/E ratio of -6.08, whereas NEPH's P/E ratio is 56.17. In terms of profitability, NXGL's ROE is -1.33%, compared to NEPH's ROE of +0.16%. Regarding short-term risk, NXGL is more volatile compared to NEPH. This indicates higher risk in terms of short-term price fluctuations for NXGL.Check NEPH's competition here
SmileDirectClub, Inc. (NASDAQ: SDC)
NXGL vs SDC Comparison October 2026
NEXGEL, Inc. (NASDAQ: NXGL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGL stands at 90.2K. In comparison, SDC has a market cap of 29.1M. Regarding current trading prices, NXGL is priced at $4.11 on the NASDAQ, while SDC trades at $0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGL currently has a P/E ratio of -6.08, whereas SDC's P/E ratio is -0.03. In terms of profitability, NXGL's ROE is -1.33%, compared to SDC's ROE of -1.96%. Regarding short-term risk, NXGL is less volatile compared to SDC. This indicates lower risk in terms of short-term price fluctuations for NXGL.Check SDC's competition here
Milestone Scientific Inc. (AMEX: MLSS)
NXGL vs MLSS Comparison October 2026
NEXGEL, Inc. (NASDAQ: NXGL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGL stands at 90.2K. In comparison, MLSS has a market cap of 27.7M. Regarding current trading prices, NXGL is priced at $4.11 on the NASDAQ, while MLSS trades at $0.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGL currently has a P/E ratio of -6.08, whereas MLSS's P/E ratio is -6.11. In terms of profitability, NXGL's ROE is -1.33%, compared to MLSS's ROE of -1.49%. Regarding short-term risk, NXGL is less volatile compared to MLSS. This indicates lower risk in terms of short-term price fluctuations for NXGL.Check MLSS's competition here
Invacare Corporation (NYSE: IVC)
NXGL vs IVC Comparison October 2026
NEXGEL, Inc. (NASDAQ: NXGL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGL stands at 90.2K. In comparison, IVC has a market cap of 24.9M. Regarding current trading prices, NXGL is priced at $4.11 on the NASDAQ, while IVC trades at $0.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGL currently has a P/E ratio of -6.08, whereas IVC's P/E ratio is -0.79. In terms of profitability, NXGL's ROE is -1.33%, compared to IVC's ROE of -0.46%. Regarding short-term risk, NXGL is more volatile compared to IVC. This indicates higher risk in terms of short-term price fluctuations for NXGL.Check IVC's competition here
Retractable Technologies, Inc. (AMEX: RVP)
NXGL vs RVP Comparison October 2026
NEXGEL, Inc. (NASDAQ: NXGL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGL stands at 90.2K. In comparison, RVP has a market cap of 17.5M. Regarding current trading prices, NXGL is priced at $4.11 on the NASDAQ, while RVP trades at $0.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGL currently has a P/E ratio of -6.08, whereas RVP's P/E ratio is -4.87. In terms of profitability, NXGL's ROE is -1.33%, compared to RVP's ROE of -0.05%. Regarding short-term risk, NXGL is more volatile compared to RVP. This indicates higher risk in terms of short-term price fluctuations for NXGL.Check RVP's competition here
Jin Medical International Ltd. (NASDAQ: ZJYL)
NXGL vs ZJYL Comparison October 2026
NEXGEL, Inc. (NASDAQ: NXGL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGL stands at 90.2K. In comparison, ZJYL has a market cap of 15M. Regarding current trading prices, NXGL is priced at $4.11 on the NASDAQ, while ZJYL trades at $1.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGL currently has a P/E ratio of -6.08, whereas ZJYL's P/E ratio is 13.13. In terms of profitability, NXGL's ROE is -1.33%, compared to ZJYL's ROE of +0.04%. Regarding short-term risk, NXGL is less volatile compared to ZJYL. This indicates lower risk in terms of short-term price fluctuations for NXGL.Check ZJYL's competition here
Bionano Genomics, Inc. (NASDAQ: BNGO)
NXGL vs BNGO Comparison October 2026
NEXGEL, Inc. (NASDAQ: NXGL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGL stands at 90.2K. In comparison, BNGO has a market cap of 14.4M. Regarding current trading prices, NXGL is priced at $4.11 on the NASDAQ, while BNGO trades at $1.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGL currently has a P/E ratio of -6.08, whereas BNGO's P/E ratio is -0.40. In terms of profitability, NXGL's ROE is -1.33%, compared to BNGO's ROE of -0.79%. Regarding short-term risk, NXGL is more volatile compared to BNGO. This indicates higher risk in terms of short-term price fluctuations for NXGL.Check BNGO's competition here
Femasys Inc. (NASDAQ: FEMY)
NXGL vs FEMY Comparison October 2026
NEXGEL, Inc. (NASDAQ: NXGL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGL stands at 90.2K. In comparison, FEMY has a market cap of 11.5M. Regarding current trading prices, NXGL is priced at $4.11 on the NASDAQ, while FEMY trades at $1.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGL currently has a P/E ratio of -6.08, whereas FEMY's P/E ratio is -0.31. In terms of profitability, NXGL's ROE is -1.33%, compared to FEMY's ROE of -2.26%. Regarding short-term risk, NXGL is more volatile compared to FEMY. This indicates higher risk in terms of short-term price fluctuations for NXGL.Check FEMY's competition here
Regentis Biomaterials Ltd. (AMEX: RGNT)
NXGL vs RGNT Comparison October 2026
NEXGEL, Inc. (NASDAQ: NXGL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGL stands at 90.2K. In comparison, RGNT has a market cap of 9.1M. Regarding current trading prices, NXGL is priced at $4.11 on the NASDAQ, while RGNT trades at $1.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGL currently has a P/E ratio of -6.08, whereas RGNT's P/E ratio is -0.53. In terms of profitability, NXGL's ROE is -1.33%, compared to RGNT's ROE of N/A. Regarding short-term risk, NXGL is more volatile compared to RGNT. This indicates higher risk in terms of short-term price fluctuations for NXGL.Check RGNT's competition here
Lucyd, Inc (NASDAQ: LUCY)
NXGL vs LUCY Comparison October 2026
NEXGEL, Inc. (NASDAQ: NXGL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGL stands at 90.2K. In comparison, LUCY has a market cap of 7.1M. Regarding current trading prices, NXGL is priced at $4.11 on the NASDAQ, while LUCY trades at $0.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGL currently has a P/E ratio of -6.08, whereas LUCY's P/E ratio is -0.63. In terms of profitability, NXGL's ROE is -1.33%, compared to LUCY's ROE of -0.89%. Regarding short-term risk, NXGL is more volatile compared to LUCY. This indicates higher risk in terms of short-term price fluctuations for NXGL.Check LUCY's competition here
NanoString Technologies, Inc. (NASDAQ: NSTG)
NXGL vs NSTG Comparison October 2026
NEXGEL, Inc. (NASDAQ: NXGL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGL stands at 90.2K. In comparison, NSTG has a market cap of 5.1M. Regarding current trading prices, NXGL is priced at $4.11 on the NASDAQ, while NSTG trades at $0.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGL currently has a P/E ratio of -6.08, whereas NSTG's P/E ratio is -0.03. In terms of profitability, NXGL's ROE is -1.33%, compared to NSTG's ROE of -1.43%. Regarding short-term risk, NXGL is less volatile compared to NSTG. This indicates lower risk in terms of short-term price fluctuations for NXGL.Check NSTG's competition here
Cuprina Holdings (Cayman) Limited Class A Ordinary Shares (NASDAQ: CUPR)
NXGL vs CUPR Comparison October 2026
NEXGEL, Inc. (NASDAQ: NXGL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGL stands at 90.2K. In comparison, CUPR has a market cap of 4.9M. Regarding current trading prices, NXGL is priced at $4.11 on the NASDAQ, while CUPR trades at $1.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGL currently has a P/E ratio of -6.08, whereas CUPR's P/E ratio is -1.32. In terms of profitability, NXGL's ROE is -1.33%, compared to CUPR's ROE of -0.85%. Regarding short-term risk, NXGL is less volatile compared to CUPR. This indicates lower risk in terms of short-term price fluctuations for NXGL.Check CUPR's competition here
Predictive Oncology Inc. (NASDAQ: POAI)
NXGL vs POAI Comparison October 2026
NEXGEL, Inc. (NASDAQ: NXGL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGL stands at 90.2K. In comparison, POAI has a market cap of 3.6M. Regarding current trading prices, NXGL is priced at $4.11 on the NASDAQ, while POAI trades at $4.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGL currently has a P/E ratio of -6.08, whereas POAI's P/E ratio is -0.38. In terms of profitability, NXGL's ROE is -1.33%, compared to POAI's ROE of -21.19%. Regarding short-term risk, NXGL is less volatile compared to POAI. This indicates lower risk in terms of short-term price fluctuations for NXGL.Check POAI's competition here
Meihua International Medical Technologies Co., Ltd. (NASDAQ: MHUA)
NXGL vs MHUA Comparison October 2026
NEXGEL, Inc. (NASDAQ: NXGL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGL stands at 90.2K. In comparison, MHUA has a market cap of 2.4M. Regarding current trading prices, NXGL is priced at $4.11 on the NASDAQ, while MHUA trades at $7.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGL currently has a P/E ratio of -6.08, whereas MHUA's P/E ratio is 0.25. In terms of profitability, NXGL's ROE is -1.33%, compared to MHUA's ROE of +0.07%. Regarding short-term risk, NXGL is more volatile compared to MHUA. This indicates higher risk in terms of short-term price fluctuations for NXGL.Check MHUA's competition here
G Medical Innovations Holdings Ltd (NASDAQ: GMVD)
NXGL vs GMVD Comparison October 2026
NEXGEL, Inc. (NASDAQ: NXGL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGL stands at 90.2K. In comparison, GMVD has a market cap of 1.8M. Regarding current trading prices, NXGL is priced at $4.11 on the NASDAQ, while GMVD trades at $0.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGL currently has a P/E ratio of -6.08, whereas GMVD's P/E ratio is -0.01. In terms of profitability, NXGL's ROE is -1.33%, compared to GMVD's ROE of +2.09%. Regarding short-term risk, NXGL is less volatile compared to GMVD. This indicates lower risk in terms of short-term price fluctuations for NXGL.Check GMVD's competition here
G Medical Innovations Holdings Ltd (NASDAQ: GMVDW)
NXGL vs GMVDW Comparison October 2026
NEXGEL, Inc. (NASDAQ: NXGL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGL stands at 90.2K. In comparison, GMVDW has a market cap of 1.8M. Regarding current trading prices, NXGL is priced at $4.11 on the NASDAQ, while GMVDW trades at $7.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGL currently has a P/E ratio of -6.08, whereas GMVDW's P/E ratio is N/A. In terms of profitability, NXGL's ROE is -1.33%, compared to GMVDW's ROE of +3.68%. Regarding short-term risk, NXGL is less volatile compared to GMVDW. This indicates lower risk in terms of short-term price fluctuations for NXGL.Check GMVDW's competition here
Avinger, Inc. (NASDAQ: AVGR)
NXGL vs AVGR Comparison October 2026
NEXGEL, Inc. (NASDAQ: NXGL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGL stands at 90.2K. In comparison, AVGR has a market cap of 1.5M. Regarding current trading prices, NXGL is priced at $4.11 on the NASDAQ, while AVGR trades at $0.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGL currently has a P/E ratio of -6.08, whereas AVGR's P/E ratio is -0.05. In terms of profitability, NXGL's ROE is -1.33%, compared to AVGR's ROE of +17.82%. Regarding short-term risk, NXGL is less volatile compared to AVGR. This indicates lower risk in terms of short-term price fluctuations for NXGL.Check AVGR's competition here
NEXGEL, Inc. (NASDAQ: NXGLW)
NXGL vs NXGLW Comparison October 2026
NEXGEL, Inc. (NASDAQ: NXGL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGL stands at 90.2K. In comparison, NXGLW has a market cap of 868.5K. Regarding current trading prices, NXGL is priced at $4.11 on the NASDAQ, while NXGLW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGL currently has a P/E ratio of -6.08, whereas NXGLW's P/E ratio is -0.02. In terms of profitability, NXGL's ROE is -1.33%, compared to NXGLW's ROE of -1.33%. Regarding short-term risk, NXGL is more volatile compared to NXGLW. This indicates higher risk in terms of short-term price fluctuations for NXGL.Check NXGLW's competition here
Lucyd, Inc (NASDAQ: LUCYW)
NXGL vs LUCYW Comparison October 2026
NEXGEL, Inc. (NASDAQ: NXGL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGL stands at 90.2K. In comparison, LUCYW has a market cap of 296.1K. Regarding current trading prices, NXGL is priced at $4.11 on the NASDAQ, while LUCYW trades at $0.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGL currently has a P/E ratio of -6.08, whereas LUCYW's P/E ratio is N/A. In terms of profitability, NXGL's ROE is -1.33%, compared to LUCYW's ROE of -0.89%. Regarding short-term risk, NXGL is less volatile compared to LUCYW. This indicates lower risk in terms of short-term price fluctuations for NXGL.Check LUCYW's competition here
Invuity, Inc. (NASDAQ: IVTY)
NXGL vs IVTY Comparison October 2026
NEXGEL, Inc. (NASDAQ: NXGL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGL stands at 90.2K. In comparison, IVTY has a market cap of 0. Regarding current trading prices, NXGL is priced at $4.11 on the NASDAQ, while IVTY trades at $7.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGL currently has a P/E ratio of -6.08, whereas IVTY's P/E ratio is -3.80. In terms of profitability, NXGL's ROE is -1.33%, compared to IVTY's ROE of -2.40%. Regarding short-term risk, NXGL is more volatile compared to IVTY. This indicates higher risk in terms of short-term price fluctuations for NXGL.Check IVTY's competition here
Hill-Rom Holdings, Inc. (NYSE: HRC)
NXGL vs HRC Comparison October 2026
NEXGEL, Inc. (NASDAQ: NXGL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGL stands at 90.2K. In comparison, HRC has a market cap of 0. Regarding current trading prices, NXGL is priced at $4.11 on the NASDAQ, while HRC trades at $155.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGL currently has a P/E ratio of -6.08, whereas HRC's P/E ratio is 41.92. In terms of profitability, NXGL's ROE is -1.33%, compared to HRC's ROE of +0.14%. Regarding short-term risk, NXGL is more volatile compared to HRC. This indicates higher risk in terms of short-term price fluctuations for NXGL.Check HRC's competition here
IntriCon Corporation (NASDAQ: IIN)
NXGL vs IIN Comparison October 2026
NEXGEL, Inc. (NASDAQ: NXGL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGL stands at 90.2K. In comparison, IIN has a market cap of 0. Regarding current trading prices, NXGL is priced at $4.11 on the NASDAQ, while IIN trades at $24.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGL currently has a P/E ratio of -6.08, whereas IIN's P/E ratio is 226.45. In terms of profitability, NXGL's ROE is -1.33%, compared to IIN's ROE of -0.00%. Regarding short-term risk, NXGL is more volatile compared to IIN. This indicates higher risk in terms of short-term price fluctuations for NXGL.Check IIN's competition here
Antares Pharma, Inc. (NASDAQ: ATRS)
NXGL vs ATRS Comparison October 2026
NEXGEL, Inc. (NASDAQ: NXGL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGL stands at 90.2K. In comparison, ATRS has a market cap of 0. Regarding current trading prices, NXGL is priced at $4.11 on the NASDAQ, while ATRS trades at $5.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGL currently has a P/E ratio of -6.08, whereas ATRS's P/E ratio is 14.95. In terms of profitability, NXGL's ROE is -1.33%, compared to ATRS's ROE of +0.31%. Regarding short-term risk, NXGL is more volatile compared to ATRS. This indicates higher risk in terms of short-term price fluctuations for NXGL.Check ATRS's competition here
Apria, Inc. (NASDAQ: APR)
NXGL vs APR Comparison October 2026
NEXGEL, Inc. (NASDAQ: NXGL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGL stands at 90.2K. In comparison, APR has a market cap of 0. Regarding current trading prices, NXGL is priced at $4.11 on the NASDAQ, while APR trades at $37.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGL currently has a P/E ratio of -6.08, whereas APR's P/E ratio is 22.59. In terms of profitability, NXGL's ROE is -1.33%, compared to APR's ROE of +9.81%. Regarding short-term risk, NXGL is more volatile compared to APR. This indicates higher risk in terms of short-term price fluctuations for NXGL.Check APR's competition here
Analogic Corporation (NASDAQ: ALOG)
NXGL vs ALOG Comparison October 2026
NEXGEL, Inc. (NASDAQ: NXGL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGL stands at 90.2K. In comparison, ALOG has a market cap of 0. Regarding current trading prices, NXGL is priced at $4.11 on the NASDAQ, while ALOG trades at $83.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGL currently has a P/E ratio of -6.08, whereas ALOG's P/E ratio is 40.93. In terms of profitability, NXGL's ROE is -1.33%, compared to ALOG's ROE of -0.15%. Regarding short-term risk, NXGL is more volatile compared to ALOG. This indicates higher risk in terms of short-term price fluctuations for NXGL.Check ALOG's competition here